drugset / Trial / NCT04380818

Low Dose Anti-inflammatory Radiotherapy for the Treatment of Pneumonia by COVID-19

NCT04380818

Non-randomizedParallel-groupOpen-labelSupportive care

Summary

Low radiation doses produce anti-inflammatory effects, which may be useful in the treatment of respiratory complications of COVID-19. This type of treatment is non-invasive and therefore, a priori, it can be used in all types of patients. Main objective: To evaluate the efficacy of low-dose lung irradiation as an adjunctive treatment in interstitial pneumonia in patients with COVID-19 by improving the PAFI O2 by 20% measured 48h after treatment with respect to the pre baseline measurement. -irradiation.

Timeline

Start
2020-06-05
Primary completion
2021-09-04
Completion
2021-11-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Azithromycin Small molecule 500 mg
Background Dexamethasone Small molecule
Background Hydroxychloroquine Small molecule 200 mg
Background Lopinavir Other / unclassified 100 mg
Background Methylprednisolone Other / unclassified
Background Prednisone Other / unclassified
Background Ritonavir Other / unclassified 400 mg
Background Tocilizumab Monoclonal antibody 600 mg

Indications